With the opening of the BRIDGE facility, Columbia will be able to house up to 12 million patient samples connected with health data to accelerate medical discovery.
John Gorman, a former Pathology faculty member, who pioneered the treatment of Rh disease in the 1960s, has been awarded Australia’s highest honor for eminent service to humanity.
Dr. Phyllis Faust's 20-year research findings could eventually help relatives of deceased essential tremor (ET) patients know their hereditary risk of getting the disease.
A new study finds that many of our genes, if disabled by a mutation, have a surprising ability to turn on backup genes to compensate for lost functions.
Teams led by Carol Troy, MD, PhD, of Columbia University, and Paraskevi Giannakakou, PhD, of Weill Cornell Medical College, each received $250,000 grants as winners of the 4th annual XSeed Award
Rh disease is a problem solved in the United States in the 1960s through Columbia research, but 50 years later, much of the world doesn’t have access to the therapy.
Pathologists Dan Green, MD, and Stephen Lagana, MD, sat down with ColumbiaDoctors to explain their jobs, describe their training, and share the most fascinating cases of their careers.